Allelotype analysis of the myelodysplastic syndrome

Leukemia

Volumn 14, Issue 5, 2000, Pages 805-810

  Xie, D ^a   Hofmann, W K ^a   Mori, N ^a   Miller, C W ^a   Hoelzer, D ^b   Koeffler, H P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Allelotype; Genetic instability; LOH; MDS; Tumor suppressor gene

Indexed keywords

MICROSATELLITE DNA;

ACROCENTRIC CHROMOSOME; ADULT; AGED; ALLELE; ARTICLE; AUTOSOME; BLOOD; BONE MARROW; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME DELETION; CLINICAL ARTICLE; CYTOGENETICS; HETEROZYGOSITY LOSS; HUMAN; LEUKEMOGENESIS; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034051860     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401717     Document Type: Article

References (45)

1. Koeffler HP. Myelodysplastic syndromes (preleukemia). Semin Hematol 1986; 23: 284-299.
2. Janssen JWG, Buschle M, Layton M, Drexler HG, Lyons J, Van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ, Bartram CR. Clonal analysis of myelodysplastic syndromes: evidence of multipotential stem cell origin. Blood 1989; 73: 248-254.
3. Bennett JM, Catovsky D, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes, Br J Haematol 1982; 51: 189-199.
4. Marshall CJ. Tumor suppressor genes. Cell 1991; 64: 313-326.
5. Goddard AD, Solomon E. Genetic aspects of cancer. In: Advances in Human Genetics. Plenum Press: New York 1993, pp 321-326.
6. Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson RA. Polymerase chain reaction-based diagnosis of del 5q in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 1996; 88: 2665-2670.
7. Fischer K, Frohling S, Scherer SW, Brown JM, Scholl B, Stigenbauer S, Tsui LC, Lichter P, Dohner H. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 1997; 89: 2036-2041.
8. Matsushima T, Murakami H, Kim K, Uchiumi H, Murata N, Tamura J, Sawamura M, Karasawa M, Naruse T, Tsuchiya J. Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der(1q;7p) chromosomal abnormality. Am J Hematol 1995; 50: 110-115.
9. Boultwood J, Fidler C. Chromosomal deletions in myelodysplasia. Leuk Lymphoma 1995; 17: 71-78.
10. Vogelstein B, Fearon EE, Kern S, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinoma. Science 1989; 244: 207-211.
11. Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R, Larson RA, LeBeau MM. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci USA 1997; 94: 6948-6953.
12. Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T. Allelotype of non-small cell lung cacinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 1992; 52: 2478-2481.
13. Sankar M, Tanaka K, Kumaravel TS, Arif M, Shintai T, Yagi S, Kyo T, Dohy H, Kamada N. Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality. Leukemia 1998; 12: 510-516.
14. Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood 1992; 79: 1501-1510.
15. Sole F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, Coll MD, Besses C, Sans-Sabrafen J. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 1992; 64: 12-20.
16. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X. Monallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809-819.
17. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995; 92: 5520-5524.
18. Praml C, Finke LH, Herfarth C, Schlag P, Schwab M, Amler L. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 1995; 11: 1357-1362.
19. Yeh S-H, Chen P-J, Chen H-L, Lai M-Y, Wang C-C, Chen D-S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 1994; 54: 4188-4192.
20. Asimakopoulos FA, Green AR. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol 1996; 95: 219-226.
21. Lai JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Lepelley P, Wattel E, Fenaux P. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations. Leukemia 1995; 9: 370-381.
22. Mori N, Morosetti R, Lee S, Spira S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP. Allelotype analysis in the evolution of chronic myelocytic leukemia. Blood 1997; 90: 2010-2014.
23. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi I, Takahashi T. Search from mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 1998; 58: 1380-1383.
24. Gedler SJ, Cohen EP, Craston A, Duhig T, Johnstone G, Barnes D. The locus of the polymorphic epithelial mucin (PEM) tumor antigen on chromosome 1q shows a high frequency of alteration in primary human breast tumors. Int J Cancer 1990; 43: 431-435.
25. Chen LC, Dollbaum C, Smith HS. Loss of heterozygosity on chromosome 1q in human breast cancer. Proc Natl Acad Sci USA 1989; 86: 7204-7207.
26. Johansson B, Brondum-Nielsen K, Billstrom R, Schiodt I, Mitelman F. Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages. Cancer Genet Cytogenet 1997; 99: 97-101.
27. Perkins D, Brennan S, Carstairs K, Bailey D, Pantalony D, Poon A, Fernandes B, Dube I. Regional cancer cytogenetics: a report on 1143 diagnostic cases. Cancer Genet Cytogenet 1997; 96: 64-80.
28. Mogul MJ, Brady K, Brothman AR, Adams R, Peterson FB, Beatty PG. Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q. Cancer Genet Cytogenet 1997; 95: 210-212.
29. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 1992; 52: 3099-3102.
30. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel T, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 1992; 52: 6525-6530.
31. Chenevix-Trech G, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Parosns PG, Friedlander M, Khoo SD. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 1992; 7: 1059-1065.
32. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-1038.
33. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Kinzler KW, Vogelstein B. Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 1625-1629.
34. Thibodeau SN, Bern G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
35. Rhyu MG, Park WS, Meltzer SJ. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 1994; 9: 29-32.
36. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993; 53: 5100-5103.
37. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O, Rachmilewitz EA. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 1996; 88: 4296-4303.
38. Zhu YM, Das-Gupta EP, Russel NH. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult leukemia. Blood 1999; 94: 733-740.
39. Tasaka T, Lee S, Spira S, Takeuchi S, Hatta Y, Nagai M, Takahara J, Koeffler HP. Infrequent microsatellite instability during the evolution of myelodysplastic syndrome to acute myelocytic leukemia. Leukemia Res 1996; 20: 113-117.
40. Kaneko H, Horiike S, Taniwaki M, Misawa S. Microsatellite instability is an early genetic event in myelodysplastic syndrome but is infrequent and not associated with TGF-beta receptor type II gene mutation. Leukemia 1996; 10: 1696-1699.
41. Harada S, Komatsu H, Seto M, Ni H, Xu JH, Hayami Y, Tsuboi K, Wakita A, Nitta M, Kato T, Ueda R. Microsatellite instability is rare in the clinical course of myelodysplastic syndrome studied with DNA from fresh and paraffin-embedded tissues. J Cancer Res Clin Oncol 1998; 124: 231-235.
42. Ben-Yehuda D. Microsatellite instability analysis in human leukemia. Rev Clin Exp Hematol 1997; 3: 71-79.
43. Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nkamura Y, Sasaki M, Ishizaki K. Allelotype analysis in osteosarcomas, frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 1992; 52: 2419-2423.
44. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG. Allelotype of human bladder cancer. Cancer Res 1994; 54: 531-538.
45. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Mutation of mitotic checkpoint genes in human cancers. Nature 1998; 392: 300-303.